PROM1 and glioblastoma: RES could act its antitumor activity on glioblastoma CD133+ tumor-initiating cells by inhibiting cell viability and growth, blocking self-renewal capacity, inducing apoptosis, and enhancing radiosensitivity in vitro and in vivo through suppression of the STAT3 street [148].